Skip to content

Relief Therapeutics Holding AG Price, Chart & Factor Analysis

Free Data & Analytics Access
Relief Therapeutics Holding AG · E.RLF.SW · Switzerland
Use symbol E.RLF.SW in our API & Excel add-in to retrieve this data ↓
1.06
(-0.63%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -100%
Trend -100%
Bubble Risk LOW
Realised Volatility (20D) 230.68%

Relief Therapeutics Holding AG Forecast

Relief Therapeutics Holding AG short-term momentum is strongly negative (up over 0 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (0 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 230.7% a year, a typical one-standard-deviation range is 0.7156–1.4044 over a week, 0.3541–1.7659 over a month and -1.3852–3.5052 over a year. (Signals as of 1 Nov 2026.)

Relief Therapeutics Holding AG Price Chart

MacroFinance.ai

Relief Therapeutics Holding AG Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Relief Therapeutics Holding AG
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Relief Therapeutics Holding AG
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Relief Therapeutics Holding AG
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Relief Therapeutics Holding AG, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Relief Therapeutics Holding AG

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Relief Therapeutics Holding AG Trading Strategies

9 backtested tactical asset allocation strategies hold VGK (European market), the closest tradable exposure to Relief Therapeutics Holding AG; 1 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

Explore all strategies →

Statistical Distribution of Returns

Plus

How Relief Therapeutics Holding AG’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Relief Therapeutics Holding AG behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Relief Therapeutics Holding AG (Switzerland)

Relief Therapeutics Holding AG is a listed security in Switzerland. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Longfor Group Holdings Limited

Frequently asked questions

What is Relief Therapeutics Holding AG?
Relief Therapeutics Holding AG is a listed security in Switzerland. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Relief Therapeutics Holding AG price?
The latest close is 1.06 (1 Nov 2026), -0.63% on the day. The price at the top of the page refreshes during the trading day.
Is Relief Therapeutics Holding AG in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly negative (0 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (0 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Relief Therapeutics Holding AG?
20-day realised volatility is 230.7% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 66.6% over a month and 32.5% over a week.
What factors affect Relief Therapeutics Holding AG?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Relief Therapeutics Holding AG, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Relief Therapeutics Holding AG?
9 backtested tactical asset allocation strategies trade Relief Therapeutics Holding AG through VGK; 1 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Relief Therapeutics Holding AG returns analysed?
The Statistical Distribution of Returns section shows the distribution of Relief Therapeutics Holding AG daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Relief Therapeutics Holding AG historical data?
In the Free historical data section of this page: the last 10 years of Relief Therapeutics Holding AG daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Relief Therapeutics Holding AG historical data (last 10 years)

Browse or instantly download the last 10 years of Relief Therapeutics Holding AG daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.RLF.SW&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2025-12-151.06
2025-12-122.885
2025-12-112.86
2025-12-102.81
2025-12-092.9
2025-12-082.95
2025-12-052.79
2025-12-042.79
2025-12-032.75
2025-12-022.76
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Relief Therapeutics Holding SA, a biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases. The company offers SETOFILM/ONDISSOLVE for nausea and vomiting associated with radiotherapy-induced, chemotherapy, and postoperative sequels; ACER-001, a sodium phenylbutyrate for the treatment of urea cycle disorders; and PKU GOLIKE for the dietary management of phenylketonuria. It also develops RLF-100, a synthetic form of vasoactive intestinal peptide for the treatment of acute respiratory distress syndrome and certain chronic lung diseases, including sarcoidosis, berylliosis, and checkpoint inhibitor-induced pneumonitis. In addition, the company develops RLF-TD011, a hypochlorous acid solution for epidermolysis bullosa. Further, it is developing RLF-OD32, a next-generation liquid sapropterin formulation for phenylketonuria. The company operates in Switzerland, Europe, North America, and internationally. Relief Therapeutics Holding SA was founded in 2013 and is based in Geneva, Switzerland.